Friday, July 10, 2026

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertensi

1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Clinical program

Biomarker

Approved · gene therapy · Transplantation, Liver

Biomarker for Transplantation, Liver is a Approved program (gene_therapy) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

← All United Therapeutics Europe Ltd projects Approved gene therapy terminated

Internal code ASF/001-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
United Therapeutics Europe Ltd
Phase
Approved
Modality
gene_therapy
Indication
Transplantation, Liver
Status
terminated
Trials
1

Clinical trials